Neuro-inflammatory risk factors for treatment failure in "early second stage" sleeping sickness patients treated with pentamidine.
Publications
Publié le
Référence de l'article:
Journal of neuroimmunology 2003 Nov ; 144(1-2); 132-8. doi: . Epub 2004 03 02